Newsroom | 7768 results

DUBLIN--(BUSINESS WIRE)--The "Pediatric Interventional Cardiology Market Report by Device Type, Procedure, End Use, Country and Company Analysis 2025 to 2033" report has been added to ResearchAndMarkets.com's offering. The Pediatric Interventional Cardiology market is poised for substantial growth, with projections estimating an increase from US$ 2.42 billion in 2024 to US$ 4.34 billion by 2033. This remarkable growth, registering a CAGR of 6.68% from 2025 to 2033, is driven by advancements in...

DENVER--(BUSINESS WIRE)--Cleerly, the leader in cardiovascular AI imaging, announces its participation in the American College of Cardiology Annual Scientific Session + Expo (ACC.25) from March 29-31, 2025, at the McCormick Place Convention Center in Chicago, Illinois. Cleerly will share its late-breaking findings on Artificial Intelligence-based Quantitative Computed Tomography’s (AI-QCT’s) role in identifying risks of future major adverse cardiovascular events (MACE) in women. Onsite, Cleerly...

AACHEN, Alemania--(BUSINESS WIRE)--Protembis, empresa privada emergente dedicada a dispositivos médicos cardiovasculares, ha anunciado hoy la creación de un Consejo Científico Asesor (SAB) que proporcionará asesoramiento objetivo y contribuirá a los planes estratégicos de la empresa. En concreto, el CCC aportará orientación estratégica científica y clínica, asesorará sobre y oportunidades emergentes y tendencias, y proporcionará asesoramiento experto sobre asuntos científicos y clínicos. El Con...

SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J. & CHICAGO--(BUSINESS WIRE)--Kardigan, a heart health company modernizing cardiovascular (CV) drug development, announced today that it has acquired Prolaio, a clinical intelligence company advancing cardiology research and care with real-world patient data and insights. In addition to its FDA-cleared patient monitoring software, Prolaio has assembled one of the largest curated CV clinical data sets in the industry and developed world-leading analyti...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place March 29-31 in Chicago. Additionally, the company will showcase new AI-powered innovations, reflecting its strategy to leverage AI to help increase efficiency and enable seamless integration of data across the cardiology care pathway. GE HealthCare has been investing in...

ROXBORO, N.C.--(BUSINESS WIRE)--Person Family Medical Center in Roxboro, NC, has selected Validic, a leader in digital health and personalized care technology, as a strategic partner to advance cardiovascular care for rural North Carolinians. Funded by a grant from the State of North Carolina and the North Carolina Department of Health and Human Resources, this collaboration will leverage Validic’s advanced digital health platform, seamlessly integrating lipoprotein(a) [Lp(a)] cholesterol scree...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how the Viz HCM module enables faster, accurate detection of signs of hypertrophic cardiomyopathy (HCM) to help ensure that more patients receive the care they need. Four studies, which will be presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo 2025, show the real-world impact of Viz.ai in...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo....

NEW YORK--(BUSINESS WIRE)--Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA). This designation recognizes PMcardio as a breakthrough technology for the detection of ST-elevation myocardial infarction (STEMI) and STEMI equivalents—a life-threatening cardiac condition requiring immediate intervention. Every 40 seconds, someone in the US suf...

NEW YORK--(BUSINESS WIRE)--Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous combination of glucose readings, blood pressure, ECGs, lung volume, respiration and hemodynamics offer unpre...